CDH5 and angiosarcoma: In the Cdh5-CreERT2, Trp53R172H/R172H cohort, 7/8 mice developed thymic lymphomas, with evidence of thymic hyperplasia in the remaining mouse, but none developed angiosarcomas (Fig. 4B).